Prof Tony Avery OBE, research co-lead for the NIHR Greater Manchester PSRC Improving Medication Safety theme, has received an Honorary Fellowship from the Royal Pharmaceutical Society Assembly – the organisation’s governing body. This is an outstanding recognition of his contributions for improving prescribing safety, invaluable as we work to enhance patient safety.

An Honorary Fellowship is awarded to those who, in the opinion of the Assembly, have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Professor Avery is a practicing GP, a Professor of Primary Health Care in the School of Medicine at the University of Nottingham, National Clinical Director for Prescribing at NHS England, and a Senior Investigator at the NIHR. Along his career, he has focused on ensuring the safe, effective, and appropriate use of medicines. He has collaborated with healthcare professionals and patients to advance research and policy development in prescribing and patient safety, and led major studies on the frequency, nature, and causes of prescribing safety issues in the NHS.

Most recently he worked with RPS on the development of the RPS/RCGP Repeat prescribing toolkit. He has also developed effective methods to address hazardous prescribing, including the pharmacist-led, IT-based intervention known as PINCER.

Professor Avery joins a distinguished group of past nominees including Professor Richard Parish, Dr David Taylor, Professor William Charman, Professor Sam Salek, Sir Richard Sykes Dr Stewart Adams, Prince Philip, Duke of Edinburgh (1955) who was the first recipient and Anne, Princess Royal (2001).

Professor Tony Avery said:

 “I am absolutely delighted that the RPS assembly has agreed to award me an Honorary Fellowship of the Society. This is a great honour to me, as I have been a strong advocate for the pharmacy profession throughout my career. As a GP I witness the excellent work of pharmacy teams on a daily basis in both community pharmacy and general practice. As a researcher, my studies have demonstrated the positive impact pharmacists can make in medicines optimisation, particularly for improving medication safety. In my National Clinical Director for Prescribing role I work with fantastic pharmacy colleagues across the profession and I am in awe of their dedication and commitment to improving patient care.”

Paul Bennett, RPS CEO said:

“I am delighted that members of Assembly have honoured Professor Tony Avery with this prestigious award. Professor Avery is well known for his research in primary care with a focus on patient safety, prescribing errors, medication errors, medicines optimisation and electronic prescribing systems.

Having collaborated closely with RPS over several years, most recently on the development of the ‘RPS/RCGP Repeat prescribing toolkit’, his significant contributions to pharmacy and RPS are fully recognised by this well-deserved award. He has consistently championed the role of pharmacists as leaders in the field of research and policy development to support the safer use of medicines.

This award reflects the high esteem in which Professor Avery and his work is held by the Society.”

—–

This post is based on a press release originally published by RPS. You can read the full release here.

Related